---
$id: https://graph.org.ai/products/commodity/51392212
$type: Product
source: UNSPSC
code: "51392212"
title: "Piroximone"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Piroximone

**UNSPSC Code**: 51392212
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C11H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2VSD0380YB, chemically known as 2h-imidazol-2-one, 4-ethyl-1,3-dihydro-5-(4-pyridinylcarbonyl)- but generally known as piroximone, which bears US NIH Compound Identifier 55263. European Medicines Agency schedules Piroximone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09938MIG. The term PIROXIMONE is an International Non-Proprietary Name. PIROXIMONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piroximone under HS 29333999 and SITC 51574. As of Q4 2014, PIROXIMONE remains the US FDA Preferred Term for this commodity. Piroximone bears US NLM identifiers UMLS ID C0071150 and NCI Concept Code C90921. SMILES: CCC1=C(NC(=O)N1)C(=O)C2=CC=NC=C2.

